000 03967nam a22005055i 4500
001 60554
005 20200226102512.0
007 cr nn 008mamaa
008 170829s2017 ja | s |||| 0|eng d
020 _a9784431551331
_9978-4-431-55133-1
024 7 _a10.1007/978-4-431-55133-1
_2doi
035 _a(DE-He213)978-4-431-55133-1
050 4 _aR895-920
072 7 _aMMPH
_2bicssc
072 7 _aMMP
_2bicssc
072 7 _aMED008000
_2bisacsh
082 0 4 _a616.0757
_223
245 1 0 _aNeuroimaging Diagnosis for Alzheimer's Disease and Other Dementias
_h[electronic resource] /
_cedited by Hiroshi Matsuda, Takashi Asada, Aya Midori Tokumaru.
264 1 _aTokyo :
_bSpringer Japan :
_bImprint: Springer,
_c2017.
300 _aVIII, 279 p. 138 illus., 81 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1 -- Epidemiology of dementia in Japan 2 -- Diagnostic criteria for Alzheimer's disease 3 -- Pathology for Alzheimer's disease and other dementias 4 -- Structural neuroimaging in Alzheimer's disease 5 -- MRI diagnosis in other dementias 6 -- Diffusion Tensor Imaging in dementia 7 -- Arterial Spin Labeling in dementia 8 -- Magnetic Resonance Spectroscopy in dementia 9 -- Resting-state fMRI in dementia 10 -- FDG-PET in Alzheimer's disease 11 -- Amyloid PET in Alzheimer's disease 12 -- Tau PET in neurodegenerative diseases manifesting dementia 13 -- Bran perfusion SPECT in Alzheimer's disease 14 -- Neuroimaging of dementia with Lewy bodies 15 -- Neuroimaging of frontotemporal lobe degeneration 16 -- Neuroimaging study of Alzheimer's disease in population-based cohort 17 -- Handling of MRI data in a multi-center study 18 -- Standardization and quality control of PET data in a multi-center study.
520 _aThis book describes the latest modalities such as tau PET imaging for diagnosis of Alzheimer’s disease and other dementias, and also provides information on handling and analyzing imaging data that is not found in other books. In addition, it introduces routine imaging studies in the management of dementia in Japan. The prevalence of dementia has increased over the past few decades, either because of greater awareness and more accurate diagnosis, or because increased longevity has created a larger population of the elderly, the age group most commonly affected. Although only clinical assessment can lead to a diagnosis of dementia, neuroimaging in dementia is recommended by most clinical guidelines, and its adjunct role has traditionally been to exclude a mass lesion rather than to support a specific diagnosis. Neuroimaging may be also helpful for developing new strategies to achieve diagnoses as early as possible for therapies aimed at slowing the progression of neurodegenerative diseases manifesting dementia. Under these conditions, all clinicians and researchers who are involved in neuroimaging for dementia should decide which patients to scan, when imaging patients is most useful, which modality to use, how to handle imaging data from many institutions, and which analytical tool to use. This edition comprises contributions from leading Japanese experts in their fields.
650 0 _aMedicine.
650 0 _aRadiology.
650 0 _aNeuroradiology.
650 0 _aNuclear medicine.
650 1 4 _aMedicine & Public Health.
650 2 4 _aImaging / Radiology.
650 2 4 _aDiagnostic Radiology.
650 2 4 _aNuclear medicine.
650 2 4 _aNeuroradiology.
700 1 _aMatsuda, Hiroshi.
_eeditor.
700 1 _aAsada, Takashi.
_eeditor.
700 1 _aTokumaru, Aya Midori.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9784431551324
856 4 0 _uhttp://dx.doi.org/10.1007/978-4-431-55133-1
912 _aZDB-2-SME
999 _c5732
_d5732